Melatonin and REM Behavior Disorder

Chia-Mo Lin, Hsiao-Yean Chiu, Christian Guilleminault

研究成果: 雜誌貢獻回顧型文獻

摘要

REM Sleep Behavior Disorder (RBD) is commonly associated with neurodegenerative diseases and leads to abnormal and often aggressive behavior during sleep, often causing injury to selfor the bed partner. Clonazepam and melatonin have been considered as treatments of RBD, but the underlying mechanism of action is unknown. Melatonin may restore the presence of physiological REM sleep muscle atonia. A clinical protocol was established to follow patients with RBD with clinical evaluation and polysomnography (PSG). A retrospective analysis was then performed on data from 28 RBD patients. From the obtained data, melatonin 6 mg has a positive effect on both clinical manifestation and PSG findings. Most subjects responded to melatonin 6 mg with a significant decrease or absence of abnormal behavior, and less than 20% of EMG bursts during total REM time during PSG, but one patient never responded to the drug even at up to 12 mg of melatonin and 3 mg of clonazepam. Depending on the patient, more disturbed sleep was noted with melatonin alone than with he combination of both melatonin and clonazepam, and a further decrease of “wake after sleep onset” was noted at polysomnography.
原文英語
頁(從 - 到)1-9
頁數9
期刊Journal of Sleep Disorders & Therapy
2
發行號3
DOIs
出版狀態已發佈 - 2013

指紋

REM Sleep Behavior Disorder
Melatonin
Polysomnography
Clonazepam
Sleep
REM Sleep
Clinical Protocols
Neurodegenerative Diseases
Muscles
Wounds and Injuries

引用此文

Melatonin and REM Behavior Disorder. / Lin, Chia-Mo; Chiu, Hsiao-Yean; Guilleminault, Christian.

於: Journal of Sleep Disorders & Therapy, 卷 2, 編號 3, 2013, p. 1-9.

研究成果: 雜誌貢獻回顧型文獻

Lin, Chia-Mo ; Chiu, Hsiao-Yean ; Guilleminault, Christian. / Melatonin and REM Behavior Disorder. 於: Journal of Sleep Disorders & Therapy. 2013 ; 卷 2, 編號 3. 頁 1-9.
@article{4a94fa10f8964ca48f4d1fafa4351f79,
title = "Melatonin and REM Behavior Disorder",
abstract = "REM Sleep Behavior Disorder (RBD) is commonly associated with neurodegenerative diseases and leads to abnormal and often aggressive behavior during sleep, often causing injury to selfor the bed partner. Clonazepam and melatonin have been considered as treatments of RBD, but the underlying mechanism of action is unknown. Melatonin may restore the presence of physiological REM sleep muscle atonia. A clinical protocol was established to follow patients with RBD with clinical evaluation and polysomnography (PSG). A retrospective analysis was then performed on data from 28 RBD patients. From the obtained data, melatonin 6 mg has a positive effect on both clinical manifestation and PSG findings. Most subjects responded to melatonin 6 mg with a significant decrease or absence of abnormal behavior, and less than 20{\%} of EMG bursts during total REM time during PSG, but one patient never responded to the drug even at up to 12 mg of melatonin and 3 mg of clonazepam. Depending on the patient, more disturbed sleep was noted with melatonin alone than with he combination of both melatonin and clonazepam, and a further decrease of “wake after sleep onset” was noted at polysomnography.",
keywords = "Melatonin, REM behavior disorder, Treatment, Poor nocturnal sleep, Response to treatment",
author = "Chia-Mo Lin and Hsiao-Yean Chiu and Christian Guilleminault",
year = "2013",
doi = "10.4172/2167-0277.1000118",
language = "English",
volume = "2",
pages = "1--9",
journal = "Journal of Sleep Disorders & Therapy",
number = "3",

}

TY - JOUR

T1 - Melatonin and REM Behavior Disorder

AU - Lin, Chia-Mo

AU - Chiu, Hsiao-Yean

AU - Guilleminault, Christian

PY - 2013

Y1 - 2013

N2 - REM Sleep Behavior Disorder (RBD) is commonly associated with neurodegenerative diseases and leads to abnormal and often aggressive behavior during sleep, often causing injury to selfor the bed partner. Clonazepam and melatonin have been considered as treatments of RBD, but the underlying mechanism of action is unknown. Melatonin may restore the presence of physiological REM sleep muscle atonia. A clinical protocol was established to follow patients with RBD with clinical evaluation and polysomnography (PSG). A retrospective analysis was then performed on data from 28 RBD patients. From the obtained data, melatonin 6 mg has a positive effect on both clinical manifestation and PSG findings. Most subjects responded to melatonin 6 mg with a significant decrease or absence of abnormal behavior, and less than 20% of EMG bursts during total REM time during PSG, but one patient never responded to the drug even at up to 12 mg of melatonin and 3 mg of clonazepam. Depending on the patient, more disturbed sleep was noted with melatonin alone than with he combination of both melatonin and clonazepam, and a further decrease of “wake after sleep onset” was noted at polysomnography.

AB - REM Sleep Behavior Disorder (RBD) is commonly associated with neurodegenerative diseases and leads to abnormal and often aggressive behavior during sleep, often causing injury to selfor the bed partner. Clonazepam and melatonin have been considered as treatments of RBD, but the underlying mechanism of action is unknown. Melatonin may restore the presence of physiological REM sleep muscle atonia. A clinical protocol was established to follow patients with RBD with clinical evaluation and polysomnography (PSG). A retrospective analysis was then performed on data from 28 RBD patients. From the obtained data, melatonin 6 mg has a positive effect on both clinical manifestation and PSG findings. Most subjects responded to melatonin 6 mg with a significant decrease or absence of abnormal behavior, and less than 20% of EMG bursts during total REM time during PSG, but one patient never responded to the drug even at up to 12 mg of melatonin and 3 mg of clonazepam. Depending on the patient, more disturbed sleep was noted with melatonin alone than with he combination of both melatonin and clonazepam, and a further decrease of “wake after sleep onset” was noted at polysomnography.

KW - Melatonin

KW - REM behavior disorder

KW - Treatment

KW - Poor nocturnal sleep

KW - Response to treatment

U2 - 10.4172/2167-0277.1000118

DO - 10.4172/2167-0277.1000118

M3 - Review article

VL - 2

SP - 1

EP - 9

JO - Journal of Sleep Disorders & Therapy

JF - Journal of Sleep Disorders & Therapy

IS - 3

ER -